Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05465044 · ClinicalTrials.gov registry record · NA
Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
A NA study of Chronic Kidney Disease (CKD) Stage 5 and Kidney Dysfunction Requiring Dialysis (KDRD), sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 252
- Enrollment target
- 6
- Study locations
NCT05465044 is a NA study of Chronic Kidney Disease (CKD) Stage 5 and Kidney Dysfunction Requiring Dialysis (KDRD) that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 252 participants. The trial reports 6 study locations across 5 states.
The verdict
NCT05465044, a NA study of Chronic Kidney Disease (CKD) Stage 5 and Kidney Dysfunction Requiring Dialysis (KDRD), is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
- 6
- Study locations
Study Summary
In this pragmatic clinical trial, which will dovetail with Veterans' routine outpatient dialysis clinic visits in six VA medical centers, the investigators will study 252 Veterans with kidney disease who need to start dialysis treatment. If a Veteran is eligible for the study by making enough residual urine, he/she will have a 50% chance to be offered the usual three-times-per-week dialysis vs. twice-per-week dialysis that is gradually increased to three-times per- week over one year. The investigators will compare health-related quality of life, how long residual kidney function lasts, and other measures including safety in these two groups. By conducting this study, the investigators hope to understand 1) whether starting dialysis with less frequency is safe, effective, and can help Veterans and their care-partners to better cope with dialysis, and 2) if incremental dialysis can result in major cost benefits to the VA health care system, thus allowing more patients to stay in VA dialysis clinics vs. being transferred to outside clinics.
Conditions Studied
Interventions
- OTHER Twice-weekly hemodialysis with incremental crossover to thrice-weekly schedule
- OTHER Thrice-Weekly Hemodialysis
Study Locations (6)
California
- VA Long Beach Healthcare System, Long Beach, CA - Long Beach
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles
Connecticut
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT - West Haven
New Mexico
- New Mexico VA Health Care System, Albuquerque, NM - Albuquerque
New York
- Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY - New York
Tennessee
- Memphis VA Medical Center, Memphis, TN - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05465044
The ClinicalTrials.gov registry entry for NCT05465044 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Chronic Kidney Disease (CKD) Stage 5 appearing as the primary indexed condition, and to 2 interventions - of which Twice-weekly hemodialysis with incremental crossover to thrice-weekly schedule is the first listed.
NCT05465044 reports 6 study locations spanning 5 distinct geographic areas - top geographies include California, Connecticut, New Mexico.
Frequently Asked Questions
What is clinical trial NCT05465044 about?
NCT05465044 is a clinical study titled "Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)". In this pragmatic clinical trial, which will dovetail with Veterans' routine outpatient dialysis clinic visits in six VA medical centers, the investigators will study 252 Veterans with kidney disease who need to start dialysis treatment. If a Veteran is eligible for the study by making enough residu...
What is the current status of trial NCT05465044?
This trial is currently recruiting. It is a NA study. The enrollment target is 252 participants. The study started on 2023-04-01. Estimated completion is 2027-09-30.
What conditions does trial NCT05465044 study?
This clinical trial studies the following conditions: Chronic Kidney Disease (CKD) Stage 5, Kidney Dysfunction Requiring Dialysis (KDRD), Dialysis Dependency.
What interventions are being tested in trial NCT05465044?
The interventions under investigation include: Twice-weekly hemodialysis with incremental crossover to thrice-weekly schedule (OTHER), Thrice-Weekly Hemodialysis (OTHER).
Who is sponsoring clinical trial NCT05465044?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05465044 being conducted?
This trial has 6 study locations across California, Connecticut, New Mexico, New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Chronic Kidney Disease (CKD) Stage 5
All registered trials for this condition
Kidney Dysfunction Requiring Dialysis (KDRD)
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.